Crispr gene editing ready for testing in humans – Financial Times
Financial Times |
Crispr gene editing ready for testing in humans
Financial Times Ever since scientists began decoding the human genome in 1990, doctors have dreamt of a new era of medicine where illness could be treated — or even cured — by fxing flaws in a person’s DNA. Rather than using medicine to fight disease, they would be … Growth Insights on the Global CRISPR/Cas9 Tools Market, 2017 – Biotechnology, Genomics, Healthcare IndustriesMilTech |
Daily Mail |
British boy, 7, with cerebral palsy will fly to the US to be injected with stem cells taken from his younger brother …
Daily Mail Hope of reversing Jay’s symptoms seemed forlorn – until she got pregnant and gave birth to her second son, Kairus, two-and-half-years ago – Mrs Shetty said: ‘We were researching stem cell therapies on the internet – and she learnt that researchers in … Blood from umbilical cord used to treat cerebral palsyThe Times |
PBS NewsHour |
Gene therapy was a boy’s last chance to stop leukemia. And it worked.
PBS NewsHour Last August, the U.S. Food and Drug Administration (FDA) approved the treatment — the first accepted gene therapy in the nation — based on the success of clinical trials like Shaun’s. But Shaun’s family didn’t know if this day would ever come. Six … |
PBS NewsHour |
Gene therapy was a boy’s last chance to stop leukemia. And it worked.
PBS NewsHour Last August, the U.S. Food and Drug Administration (FDA) approved the treatment — the first accepted gene therapy in the nation — based on the success of clinical trials like Shaun’s. But Shaun’s family didn’t know if this day would ever come. Six … |
SelectScience |
Here’s Why Crispr Therapeutics AG Jumped Again in February
Fox Business Crispr Therapeutics expects to file an application with the FDA later this year that could allow the company to begin human trials before the end of 2018. New drug candidates in pre-clinical development have about a 1% chance of reaching an FDA review … Editorial Article: 7 Steps to Better Gene Editing and CRISPR technology – Special FeatureSelectScience CRISPR Therapeutics AG (CRSP) EPS Estimated At $-0.71Frisco Fastball 15752 Shares in Crispr Therapeutics AG (CRSP) Acquired by DA Davidson & CO.The Ledger Gazette |